🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this open-label, flexible dose study is to assess ...
Status
Terminated
Location
248.642.0026 Boehringer Ingelheim Investigational Site
Start Date
2008-05
Trial ID
NCT00681863
The primary objective of this investigation is to conduct a 12-week prospec...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2007-01
Trial ID
NCT00614575
The objective of double blind phase in this trial is to compare the efficac...
Status
Completed
Location
248.627.037 Boehringer Ingelheim Investigational Site
Start Date
2006-10
Trial ID
NCT00390689
Treatments Being Tested
The objective of this trial is to investigate the efficacy and safety of pr...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-08
Trial ID
NCT00152997
Treatments Being Tested
The long-term goal of this proposal is to identify non-opioid drugs that ha...
Status
Completed
Location
University of New Mexico Hospital
Start Date
2019-05-01
Trial ID
NCT03842709
Treatments Being Tested
The objectives of this study were to investigate relative BA at steady stat...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT02264132
Treatments Being Tested
The objective of this trial is to investigate the safety, tolerability, tro...
Status
Completed
Location
248.610.019 Boehringer Ingelheim Investigational Site
Start Date
2007-11
Trial ID
NCT00560508
Treatments Being Tested
Parkinsons Disease (PD) is caused by a decrease of dopamine in a particular...
Status
Completed
Location
248.596.43003 Boehringer Ingelheim Investigational Site
Start Date
2006-03
Trial ID
NCT00297778
Treatments Being Tested
To evaluate the efficacy and safety of long-term treatment with pramipexole...
Status
Completed
Location
Multiple Locations
Start Date
1998-12
Trial ID
NCT00274131
Treatments Being Tested